Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
暂无分享,去创建一个
Jill P. Mesirov | Dong Gao | Stuart L. Schreiber | Pablo Tamayo | John G. Doench | Michael E. Berens | Paul A. Clemons | Sarah Javaid | Mitchell P. Levesque | Brinton Seashore-Ludlow | Brent R. Stockwell | John K. Eaton | William C. Hahn | Jesse S. Boehm | Sixun Chen | Daniel A. Haber | Wan Seok Yang | Brian M. Wolpin | Andrew J. Aguirre | Jeffrey A. Engelman | John G Doench | S. Gill | J. Mesirov | P. Tamayo | W. Hahn | P. Clemons | S. Schreiber | B. Stockwell | J. Boehm | J. Doench | A. Shamji | Xiaoyun Wu | D. Haber | J. Engelman | S. Kaffenberger | M. Rees | B. Seashore-Ludlow | Sarah Javaid | J. Kotz | C. Hon | O. Eichhoff | B. Wolpin | A. Aguirre | Harshil Dhruv | M. Berens | D. Gao | S. Viswanathan | M. Ryan | M. Levesque | J. Eaton | E. Roider | Z. Boskovic | W. Yang | Yuen-Yi Tseng | Vasanthi S. Viswanathan | Matthew J. Ryan | Harshil D. Dhruv | Shubhroz Gill | Ossia M. Eichhoff | Samuel D. Kaffenberger | Kenichi Shimada | Srinivas R. Viswanathan | Shrikanta Chattopadhyay | Matthew G. Rees | Zarko V. Boskovic | Cherrie Huang | Xiaoyun Wu | Elisabeth M. Roider | James M. Cleary | Joanne D. Kotz | Cindy S. Hon | Yu Chen | Alykhan F. Shamji | K. Shimada | S. Chattopadhyay | Sixun Chen | V. Viswanathan | J. Cleary | Yu Chen | Y. Tseng | Cherrie Huang | Yuen-Yi Tseng
[1] Sridhar Ramaswamy,et al. Dynamic Chromatin Modification Sustains Epithelial-Mesenchymal Transition following Inducible Expression of Snail-1 , 2013, Cell reports.
[2] H. Howe,et al. Pathology and classification of ovarian tumors , 2003, Cancer.
[3] E. Lander,et al. Identification of a selective small molecule inhibitor of breast cancer stem cells. , 2012, Bioorganic & medicinal chemistry letters.
[4] G. Superti-Furga,et al. Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death , 2015, ACS chemical biology.
[5] L. Chung,et al. Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells , 2010, The Prostate.
[6] Ben S. Wittner,et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.
[7] Joshua A. Bittker,et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action , 2015, Nature chemical biology.
[8] G. Freeman,et al. Learning from PD-1 Resistance: New Combination Strategies. , 2016, Trends in molecular medicine.
[9] J. Wolff,et al. How long can folinic acid rescue be delayed after high‐dose methotrexate without toxicity? , 2014, Pediatric blood & cancer.
[10] Jianguo Song. EMT or apoptosis: a decision for TGF-β , 2007, Cell Research.
[11] Sourav Bandyopadhyay,et al. Epithelial-to-mesenchymal transition rewires the molecular path to PI3K-dependent proliferation. , 2014, Cancer discovery.
[12] Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma , 2015, Genome Biology.
[13] B. Carlson,et al. Inhibition of selenoprotein synthesis by selenocysteine tRNA[Ser]Sec lacking isopentenyladenosine. , 2000, The Journal of biological chemistry.
[14] Michael Peyton,et al. An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance , 2012, Clinical Cancer Research.
[15] Alexander Feuerborn,et al. Zeb1 affects epithelial cell adhesion by diverting glycosphingolipid metabolism , 2015, EMBO reports.
[16] R. Guigó,et al. Characterization of Mammalian Selenoproteomes , 2003, Science.
[17] R. Dummer,et al. In vivo switching of human melanoma cells between proliferative and invasive states. , 2008, Cancer research.
[18] Katherine R. Singleton,et al. A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop , 2013, Oncogenesis.
[19] M. R. Lamprecht,et al. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.
[20] Nicole E. Bodycombe,et al. Connecting Small Molecules with Similar Assay Performance Profiles Leads to New Biological Hypotheses , 2014, Journal of biomolecular screening.
[21] Klemens Vierlinger,et al. Meta-Analysis of Gene Expression Signatures Defining the Epithelial to Mesenchymal Transition during Cancer Progression , 2012, PloS one.
[22] P. Sorger,et al. Systems biology and combination therapy in the quest for clinical efficacy , 2006, Nature chemical biology.
[23] Kakajan Komurov,et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes , 2010, Proceedings of the National Academy of Sciences.
[24] Matthew E. Welsch,et al. Regulation of Ferroptotic Cancer Cell Death by GPX4 , 2014, Cell.
[25] Sydney M. Shaffer,et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance , 2017, Nature.
[26] Hans Clevers,et al. Organoid Cultures Derived from Patients with Advanced Prostate Cancer , 2014, Cell.
[27] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[28] J. Keith Joung,et al. Efficient Delivery of Genome-Editing Proteins In Vitro and In Vivo , 2014, Nature Biotechnology.
[29] Mala Sinha,et al. Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma , 2010, PloS one.
[30] Charles H. Yoon,et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.
[31] Li Ma,et al. ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance , 2015, Cell cycle.
[32] Petra C. Schwalie,et al. Identification of the transcription factor ZEB 1 as a central component of 1 the adipogenic gene regulatory network 2 3 , 2022 .
[33] Chris Albanese,et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. , 2012, The American journal of pathology.
[34] Joshua A. Bittker,et al. Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset. , 2015, Cancer discovery.